Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06703099Not ApplicableCompleted

Magnesium Supplementation on Body Composition

Role: collaborator

NCT02043977Phase 1Completed

Efficacy and Safety Study of Propofol Infusion for Refractory Chronic Primary Insomnia

Role: lead

NCT01716637Phase 1Completed

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Role: lead

NCT01597167Not ApplicableCompleted

Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression

Role: collaborator

All 4 trials loaded